These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7171570)

  • 21. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex.
    Husten EJ; Esmon CT; Johnson AE
    J Biol Chem; 1987 Sep; 262(27):12953-61. PubMed ID: 3477541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid.
    Boskovic DS; Giles AR; Nesheim ME
    J Biol Chem; 1990 Jun; 265(18):10497-505. PubMed ID: 2355010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A domain of membrane-bound blood coagulation factor Va is located far from the phospholipid surface. A fluorescence energy transfer measurement.
    Isaacs BS; Husten EJ; Esmon CT; Johnson AE
    Biochemistry; 1986 Aug; 25(17):4958-69. PubMed ID: 3768326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma.
    Tans G; Janssen-Claessen T; Hemker HC; Zwaal RF; Rosing J
    J Biol Chem; 1991 Nov; 266(32):21864-73. PubMed ID: 1939210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: an experimental and theoretical approach.
    Ye J; Esmon CT
    Biochemistry; 1995 May; 34(19):6448-53. PubMed ID: 7756276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinate binding of factor Va and factor Xa to the unstimulated platelet.
    Tracy PB; Nesheim ME; Mann KG
    J Biol Chem; 1981 Jan; 256(2):743-51. PubMed ID: 7451472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.
    Nesheim ME; Canfield WM; Kisiel W; Mann KG
    J Biol Chem; 1982 Feb; 257(3):1443-7. PubMed ID: 6895752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of thrombin as a probe for mixing of phospholipids in membranes on solid supports.
    Giesen PL; Hemker HC; Hermens WT
    Biochim Biophys Acta; 1995 Jul; 1237(1):43-8. PubMed ID: 7619841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipid-binding properties of bovine factor V and factor Va.
    Bloom JW; Nesheim ME; Mann KG
    Biochemistry; 1979 Oct; 18(20):4419-25. PubMed ID: 486430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
    van Dieijen G; Tans G; Rosing J; Hemker HC
    J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of unbound protein in vesicle suspensions with off-null ellipsometry.
    Giesen PL; Willems GM; Hemker HC; Stuart MC; Hermens WT
    Biochim Biophys Acta; 1993 Apr; 1147(1):125-31. PubMed ID: 8466922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C.
    Guinto ER; Esmon CT
    J Biol Chem; 1984 Nov; 259(22):13986-92. PubMed ID: 6438088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake).
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    J Biol Chem; 1986 Oct; 261(28):13258-67. PubMed ID: 3531198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding.
    Sabharwal AK; Padmanabhan K; Tulinsky A; Mathur A; Gorka J; Bajaj SP
    J Biol Chem; 1997 Aug; 272(35):22037-45. PubMed ID: 9268343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding of factor Va to phospholipid vesicles.
    Krishnaswamy S; Mann KG
    J Biol Chem; 1988 Apr; 263(12):5714-23. PubMed ID: 3162734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope mapping of functional domains of human factor Va with human and murine monoclonal antibodies. Evidence for the interaction of heavy chain with factor Xa and calcium.
    Annamalai AE; Rao AK; Chiu HC; Wang D; Duttá-Roy AK; Walsh PN; Colman RW
    Blood; 1987 Jul; 70(1):139-46. PubMed ID: 2439148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.